HKSecWiki新股資訊 2022年09月22日
01:00 AM EDT, 09/22/2022 (MT Newswires) -- Betters Medical Investment Holdings (HKG:6678) kicked off its initial public offering in Hong Kong on Thursday, undeterred by the market volatility amid concerns of a recession following a series of interest rate hikes by the US Federal Reserve.
美國東部時間2022年09月22日凌晨01：00(MT Newswres)-Betters Medical Investment Holdings(HKG：6678)周四在香港啟動首次公開募股(IPO)，在美國聯邦儲備委員會(Federal Reserve)一系列加息後對經濟衰退的擔憂中，市場波動並未嚇倒該公司。
The microwave ablation medical device maker will issue 248 million shares at HK$1.40 to HK$1.72 each, a listing that could raise as much as HK$426.6 million ($54.3 million) if priced at the upper end of the marketed range.
這傢微波消融醫療設備制造商將以每股1.40港元至1.72港元的價格發行2.48億股，如果定價在市場區間的上限，此次發行可能籌資至多4.266億港元(合5430萬美元)。
Of the total shares on offer, 24.8 million are earmarked for Hong Kong investors. An overallotment option of up to 37.2 million shares can be exercised if there is strong demand for the deal.
在此次發行的全部股票中，有2480萬股是為香港投資者指定的。如果交易需求強勁，可以行使最多3720萬股的超額配售選擇權。
Betters Med counts Bank of China (HKG:3988, SHA:601988) and IPE (HKG:0929) among its pre-IPO investors.
Betters Med的首次公開招股前投資者包括中國銀行(HKG：3988，SHA：601988)和IPE(HKG：0929)。
The Guangzhou-headquartered company expects to determine the IPO price on Sept. 27 and disclose the allocations on Oct. 3. It intends to start trading on the Hong Kong bourse on Oct. 5.
這傢總部位於廣州的公司預計將於9月9日確定IPO價格。27，並於10月3日披露配置情況。該公司計劃於10月5日在香港交易所開始交易。
Betters Medical will use the deal proceeds to broaden its product portfolio, upgrade medical licenses, enlarge the research and development team, widen the indication coverage of its existing devices, finance R&D studies and acquisitions, as well as expand its presence in overseas markets.
Betters Medical將利用這筆交易所得擴大其產品組合，升級醫療執照，擴大研發團隊，擴大其現有設備的適應癥覆蓋范圍，為研發研究和收購提供資金，以及擴大其在海外市場的存在。
BOCI Asia, Zhongtai International, China Galaxy International, Cinda International, Huatai Financial, Eddid Securities, China Everbright Securities, Guosen Securities, China Industrial Securities, Valuable Capital and ZMF Asset Management are the joint lead managers and book-runners of the IPO.
中銀亞洲、中泰國際、中國銀河國際、信達國際、華泰證券金融、愛德華德證券、中國光大證券、國信證券、中國興業證券、寶貴資本和ZMF Asset Management為是次IPO的聯席牽頭經辦人兼賬簿管理人。
本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠，亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。
Was this helpful?
0 / 0
本文链接： https://hk.hksecwiki.com/news/hkp19764291/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com